In cancer cells, decorin decreases the expression of VEGFA and HIF-1α through interfering with the signaling pathways of Hepatocyte Growth Factor (HGF/Met) and epidermal growth factor receptor (EGFR) [69]. The gene discussed is EGFR; the disease is cancer.